Assisted Reproductive Technology (ART) is a medical procedure used to help couples who are struggling to conceive. This may involve using fertility drugs to stimulate ovulation, retrieving eggs from the ovaries for in vitro fertilization, or using a donor egg or sperm. ART can be used for couples who are struggling with infertility due to age, sperm quality, or other factors.
Download Free Sample of Report – https://www.globalinsightservices.com/request-sample/GIS21521/?utm_id=1017
Key Trends
There are a few key trends in Assisted Reproductive Technology (ART) technology. One is the trend towards more personalized and targeted treatments. This means that treatments are becoming more tailored to the specific needs of the patient, rather than a one-size-fits-all approach. This is possible due to advances in genetic testing and other diagnostic tools.
Another trend is the increasing use of minimally invasive techniques. This is especially beneficial for patients who may be hesitant to undergo more invasive procedures, such as surgery. Minimally invasive techniques often have shorter recovery times and fewer risks.
Finally, there is a trend towards more affordable treatments. This is due to a variety of factors, such as the increasing use of generic medications and the development of new, more cost-effective treatments.
Report Overview- https://www.globalinsightservices.com/reports/assisted-reproductive-technology-art-market
Key Drivers
The key drivers of the Assisted Reproductive Technology (ART) market are the rising prevalence of infertility, the increasing number of women opting for ART procedures, and the growing awareness about fertility treatments.
Infertility is a global problem, affecting over 48 million couples worldwide. In the United States, it is estimated that around 6.7 million women aged 15-44 have difficulty conceiving or carrying a pregnancy to term.
ART procedures are expensive and are not covered by most insurance plans. The cost of a single cycle of in vitro fertilization (IVF) can range from $10,000 to $15,000. This, coupled with the emotional stress of undergoing fertility treatments, can deter many couples from pursuing ART.
However, the success rates of ART procedures have been increasing, with the live birth rate for IVF now estimated to be around 35%. This, along with the growing awareness of fertility treatments, is likely to drive the ART market in the coming years.
Restraints & Challenges
There are a number of key restraints and challenges in the Assisted Reproductive Technology (ART) market. Firstly, the high cost of ART procedures can be a significant barrier for many couples or individuals seeking treatment.
Get a customized scope to match your need, ask an expert – https://www.globalinsightservices.com/request-customization/GIS21521/?utm_id=1017
Secondly, the success rates of ART procedures are still relatively low in comparison to other fertility treatments, such as in vitro fertilization (IVF). This means that many couples may undergo multiple cycles of treatment before they are successful in conceiving a child.
Thirdly, there is a lack of awareness of ART procedures among the general public, which can be a barrier to couples or individuals seeking treatment.
Finally, there is a lack of regulation around ART procedures in many countries, which can lead to concerns about the safety and efficacy of these treatments.
Market Segmentation
The assisted reproductive technology market is segmented on the basis of product, technology, and region. By product, the market is categorized into instrument, accessory & disposable and reagent & media. The instrument segment is further classified into sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, cabinet, micromanipulator, laser systems, and others. The reagent & media segment is further divided into cryopreservation media, semen processing media, ovum processing media, and embryo culture media. By technology, it is divided into in vitro fertilization, artificial insemination, and others.
Key Players
The key Players in the assisted reproductive technology market are Cook Medical Inc., Fujifilm Holdings Corporation , Genea Biomedx, Merck KGaA , Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc., Thermo Fisher Scientific, Inc. and Vitrolife AB.
Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS21521/?utm_id=1017
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/